Assessment of endoscopic mucosal healing of inflammatory bowel disease using linked color imaging (LCI), a novel endoscopic enhancement system

Assessment of endoscopic mucosal healing of inflammatory bowel disease using linked color imaging (LCI), a novel endoscopic enhancement system - The usefulness of LCI for endoscopic diagnosis of inflammatory bowel disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017990

Enrollment

300

Registered

2015-08-01

Start date

2015-11-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients diagnosed as ulcerative colitis and Crohn's disease based on the criteria of Japanese Ministry of Health, Specific disease intractable inflammation-related intestinal tract disorder research group.

Exclusion criteria

Exclusion criteria: a) Re-registration example to the examination b) The patients with malignant tumor c) The patients with surgical operation within 12 weeks d) In addition, the patient who judged an arrangement to the examination if the medical attendant was inappropriate

Design outcomes

Primary

Measure	Time frame
Correlation between LCI findings, digitization of LCI and intestinal mucosal inflammation, cytokine mRNA expression.	—

Secondary

Measure	Time frame
Correlation between LCI findings, digitization of LCI and prognosis of UC and CD.	—

Countries

Japan

Contacts

Public ContactKazuhiko Uchiyama

Kyoto Prefectural University of Medicine Molecular Gastroenterology and Hepatology

k-uchi@koto.kpu-m.ac.jp075-251-5519

Outcome results